Wedge Networks announces general availability of its innovative, Continuous Learning Analytics and Threat Intelligence Engine, WedgeIQ™ Nucleation Edition at Asia Tech Singapore

June 6, 2023

Wedge Networks (Wedge) today announced the General Availability (GA) of WedgeIQ™ Nucleation Edition, an innovative, continuous machine-learning based Security Operations, Incident, and Event Management (SIEM) and analytics engine, at Asia Tech x Singapore, Asia’s premier tech event. Developed as a licensable component of the advanced WedgeARP™ software platform, WedgeIQ™ Nucleation Edition offers a potent response to today’s pressing cybersecurity challenges, particularly the increasingly sophisticated, never-before-seen malware that outmaneuvers current defense systems where Wedge’s patented continuous AI engines are continuously learning to respond to such attacks.

Biotricity, News

Biotricity reaches $13M revenue run rate in April 2023 on accelerating growth

May 16, 2023

Biotricity Inc. (Biotricity) today reported that it reached a record $13 million annualized revenue run rate in April, further extending its growth by over eight percent from the $12 million run rate it announced for March 2023. In its Corporate Impact Report published earlier this month, Biotricity described both “better patient outcomes and substantial cost savings” for patients using its devices.

News, Wedge Networks

Wedge Networks teams up with Edgecore Networks to offer next-generation network security WedgeCND™ Add-on now available on Edgecore ecCLOUD

May 8, 2023

Wedge Networks Inc. (“Wedge”) today announced that Edgecore Networks, a leading provider of traditional and open network solutions for enterprises, data centers, and telecommunication service providers, has partnered with Wedge Networks to offer a next-generation network security solution to its customers. Wedge Networks’ Wedge Cloud Network Defense (WedgeCND™), is a cloud-managed security service designed to provide comprehensive security protection.

News, Wedge Networks

Wedge Networks partners with Seaspring to deliver real-time threat prevention to the Bahrain & MENA Markets

January 31, 2023

Wedge Networks Inc. (“Wedge”) today announced the signing of a Distributor Agreement with Seaspring W.L.L. (“Seaspring”), a Bahrain-based international investment consultancy firm and a Wedge shareholder. This collaboration aims at delivering innovative cyberthreat prevention solutions to enterprises, small businesses, government departments, service providers, and data centres, while simultaneously expanding the Company’s presence in the region. Together, Wedge and Seaspring will bring the Wedge Absolute Real-Time Protection (“WedgeARP™”) Series, an exclusive real-time threat prevention solutions in the industry, to the active markets of Bahrain and the MENA region.

Healthcare, News

Asep Inc. signs Letter of Intent for joint venture with Bahrain-based Seaspring W.L.L. for regulatory approval and commercialization of sepsis diagnosis technology

January 6, 2023

Asep Medical Holdings Inc. (Asep Inc.) is delighted to announce the recent signing of a Letter of Intent (LOI) for a joint venture between Asep Inc. and Seaspring W.L.L (Seaspring). The joint venture will be owned 50/50 between Asep Inc. and Seaspring pursuant to a definitive agreement. As per the terms of the LOI that was signed by both parties on December 11, 2022 in Bahrain, Seaspring will contribute the capital required by the joint venture to conduct its business operations while Asep Inc. will provide the licensing rights for use of the technology in the Kingdom of Bahrain and the Middle East and North Africa (MENA) region.

Biotricity, News

Biotricity surpasses $10 million in annual revenue run rate

November 21, 2022

Biotricity Inc. (Biotricity) today announced it has surpassed $10 million in annual revenue run rate. “With strong revenue growth each quarter, our scale and market reach increases every day. I am committed to continuing to drive growth and realize our potential,” says Biotricity Founder and CEO, Dr. Waqaas Al-Siddiq.

Biotricity, News

Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions

November 16, 2022

Biotricity Inc. (Biotricity) has signed a distribution agreement with one of the Top 10 US medical device distributors to distribute its cardiac monitoring solutions, Bioflux and Biotres. With the commercialization of its Bioflux and Biotres products, Biotricity has increased its total addressable market from $1 billion to approximately $6 billion.

Biotricity, News

Biotricity’s Bioheart named to TIME’s list of The Best Inventions of 2022

November 10, 2022

Biotricity Inc. (Biotricity) today announced that its Bioheart device has been named to TIME’s list of the Best Inventions of 2022. Bioheart is the first of its kind – a continuous heart rhythm monitor using advanced technology to deliver unlimited heart data insights.

Biotricity, News

Biotricity launches Cardiac Disease Management Solution following 2 successful pilots with Oklahoma & Kentucky Clinics

October 26, 2022

Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac. The national roll-out follows two successful pilot programs in Oklahoma City with CardioVascular Health Clinic, a medical facility providing high-quality cardiovascular care to more than 40,000 patients, and a four-month pilot with Lexington Heart Specialists in Kentucky, a medical practice providing high-quality cardiovascular care to more than 20,000 patients.

Biotricity, News

Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib)

October 4, 2022

Biotricity Inc. (Biotricity) today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux®, Biotricity’s high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient’s ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux’s built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence (AI).